Biotechnology & Medical Research

MediciNova, Inc announces FDA granted orphan drug designation to MN-001 for Idiopathic Pulmonary Fibrosis

MediciNova, Inc:Says that the U.S. Food and Drug Administration has granted orphan-drug designation to MN-001 (tipelukast) for treatment of idiopathic pulmonary fibrosis.Says Orphan-drug designation will provide MediciNova with seven years of marketing exclusivity for MN-001 (tipelukast) for the...

7:00pm EDT

Acorda Therapeutics Inc completes acquisition of Civitas Therapeutics

Acorda Therapeutics Inc:Completes its acquisition of Civitas Therapeutics and obtained global rights to CVT-301.Acquisition also included rights to the proprietary ARCUS((reg))pulmonary delivery technology, and a manufacturing facility with commercial-scale capabilities based in Chelsea, MA.Under...

4:11pm EDT

Transgenomic Inc announces $2.375 mln private placement financing

Transgenomic Inc:Raises gross proceeds of about $2.375 mln in a private placement financing with a syndicate of new and existing institutional and other accredited investors. The company's common shares were priced at $3.25 per share, which represents a premium to the closing stock price on Oct. 21,...

4:05pm EDT

Sangamo Biosciences Inc reiterates FY 2014 revenue guidance

Sangamo Biosciences Inc:Reiterates earlier FY 2014 revenue guidance.Expects revenues will be in the range of $45 million to $50 million in FY 2014, inclusive of research funding and certain milestone payments from Shire and Biogen.FY 2014 revenue of $48 million - Thomson Reuters I/B/E/S.

4:03pm EDT


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Thomson Reuters StreetEvents
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.